2022
DOI: 10.1007/s00381-022-05468-w
|View full text |Cite
|
Sign up to set email alerts
|

Spinal astroblastoma: a rare tumour in an unusual location

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 12 publications
1
5
0
Order By: Relevance
“…17 Both of the previously described MN1 altered spinal astroblastomas responded well to intensity-modulated radiation therapy and temozolamide. 4,5 In our case, 3 months after GTR, no residual disease was found in postcontrast scan. As the role of adjuvant radiotherapy and chemotherapy is not properly defined, there is little literature regarding spinal astroblastomas; gross total removal of the tumor was achieved, and the child was given only supportive care and kept under close follow-up.…”
Section: Discussionsupporting
confidence: 47%
See 4 more Smart Citations
“…17 Both of the previously described MN1 altered spinal astroblastomas responded well to intensity-modulated radiation therapy and temozolamide. 4,5 In our case, 3 months after GTR, no residual disease was found in postcontrast scan. As the role of adjuvant radiotherapy and chemotherapy is not properly defined, there is little literature regarding spinal astroblastomas; gross total removal of the tumor was achieved, and the child was given only supportive care and kept under close follow-up.…”
Section: Discussionsupporting
confidence: 47%
“…Among the previously reported cases of spinal astroblastoma, one, reported by Yamada et al 4 occurred in a 20-year-old female involving the T1-T2 level of the spinal cord, and another, reported by Rao et al, 5 occurred in a 16-year-old boy involving the T11-T12 level of the spinal cord; both harbored MN1 alterations. While the third case, reported by Yamasaki et al, 6 which occurred in a 3-month-old child involving the lower portion of the medulla to the C4 level, was classified as a high-grade neuroepithelial tumor (HGNET) with MN1 alteration based on methylation assay, despite having EWSRI-BEND2 fusion detected on RNA sequencing and lack of MN1 alteration demonstrated by both FISH and RNA sequencing.…”
Section: Discussionmentioning
confidence: 97%
See 3 more Smart Citations